Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis: Post-Hoc Analysis of the SUPREME Study.

Marina Talamonti Filomena RussoGiovanna MalaraKatharina HanselManuela PapiniAngelo CattaneoAurora ParodiAndrea ChiricozziPiergiorgio MalagoliFederico BardazziValeria BrazzelliPaolo DapavoPaolo GisondiCristina ZaneConcetta PotenzaFranca CantoresiMaria-Concetta FargnoliSara TrevisiniPina BriantiLeonardo PescitelliGiovanni GiganteMarta BartezaghiLuisa CaputoElisabetta AloisiAntonio Costanzonull null

Published in: Clinical, cosmetic and investigational dermatology (2023)

Secukinumab is a valid option for the management of moderate to severe psoriasis in elderly patients.

Keyphrases

ankylosing spondylitis
high intensity
early onset
coronary artery disease
atopic dermatitis
rheumatoid arthritis
middle aged
community dwelling
systemic lupus erythematosus